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ABSTRACT  
Background: The prevalence of osteoarthritis (OA) in the community is high. This disease is the 
second most common cause of physical disability worldwide. Pain in OA is caused by several 
factors, such as inflammation. Non steroidal anti-inflammatory drugs (NSAIDs) were the most 
common drugs given worldwide to reduce pain in OA. NSAIDs were also associated with a high 
incidence of gastrointestinal side effects. An alternative to manage this problem is by using the 
combination of Curcuma xantorrhyza Roxb. (commonly known as temulawak) extract, ginger 
(Zingiber officinale) extract, soybean (Glycine max), and shrimp shell. Curcuma xantorrhyza 
contains curcumin which has anti-inflammatory effect by suppressing cyclo-oxygenase (COX-2) 
enzyme activity, suppressing lipo-oxygenase enzyme activity, and play a role as a free radical 
scavenger. Ginger can inhibit COX-2 activity in PGE-2 production. Shrimps shell contains 
glucosamine and chondroitin which can increase proteoglycan in articular chondrocytes and 
inhibit COX-2 synthesis. Isoflavone in soybean can inhibit articular cartilage degradation and 
COX-2 synthesis.  
Study Aims: The purpose of this study is to compare the effect of the combination to diclofenac 
sodium in reducing synovial fluid leukocyte count and joint pain in patients with osteoarthritis.  
Sudy Method:This study was a prospective randomized open end blinded evaluation (PROBE). 
Twenty one patients with knee osteoarthritis diagnosed by American College of Rheumatology 
criteria were included in this study. Patients were randomized into two groups to receive either 
diclofenac sodium 25 mg (control group) or the combination of Curcuma xantorrhyza extract 50 
mg, ginger extract 100 mg, shrimp shell 100 mg, and soy bean flour 50 mg (treatment group) 
three times daily for 14 days. Independent t-tests and Mann-Whitney-Wilcoxon tests were used to 
evaluate changes between  prior and post intervention. 
Results:  There were significantly reduction of synovial fluid leukocyte count in both control 
group (p=0.017) and treatment group (p=0.008) respectively.  The reduction of synovial fluid 
leukocyte count was not significantly different between control group and treatment group 
(p=0.929).  There were significant Improvement of joint pain (VAS score) in both control group 
(p=0.012) and treatment group (p<0.001).  The reduction of VAS score was not significantly 
different between diclofenac group and treatment group (p=0.607). Conclusion: These results 
indicate that the evicacy of this combiation was not significantly different with diclofenac sodium 
in reducing the synovial fluid leukocyte count and joint pain in patients with osteoarthritis. 
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INTRODUCTION 
steoarthritis is a joint disease which occurs because of joint cartilage changes, sclerosis of 
subchondral bones, and inflammation. Osteoarthritis (OA) is a rheumatic disease with the highest 
prevalence among all rheumatic diseases. Osteoarthritis is the second leading cause of physical 
disability in the world after ischemic heart disease. This disease causes a major loss of working 
hours and has a high cost of treatment
1
. 
World Health Organization (WHO) estimates that 40% of the population of people above 
70 years of age suffers from OA and 80% of OA patients have limitation in movement ranging in 
various degrees from mild to severe which leads to the deterioration of quality of life. 
Osteoarthritis prevalence increases with age
2
. 
Joint pain can haunt the patients with osteoarthritis every time. Pain in osteoarthritis is still 
difficult to explain, which occurs because of the combination of many factors, one of them is 
inflammation
3
. Concept of pain in OA caused by inflammation has some evidences, such as the 
increase of synovial fluid leukocyte count over 200cells/mm
3
 and the presence of many pro-
inflammatory mediators in the synovial fluid
4
. Pain in osteoarthritis is chronic, thus need some 
pain killer or anti-inflammatory drugs. Anti-inflammatory drugs which widely used are non-
steroidal anti-inflammatory drugs (NSAIDs) which work by inhibiting cyclooxygenase-1 (COX-
1) and cyclooxygenase-2 (COX-2) enzyme activities. The suppression of COX-2 enzyme 
activities can inhibit the forming of E-2 prostaglandin thus hampering the process of joint 
inflammation. Studies have shown that NSAIDs have serious adverse effects mainly if used in a 
long period, especially in elderly patients. The adverse effects of NSAIDs can be gastrointestinal 
bleeding, liver function disorder, kidney disorder, bone marrow disorder, heart attack and stroke 
5
.   
The natural ingredients to treat diseases has been used for thousands years in Indonesia or 
other countries. Study data in Malang City and District shows that residents using herbal 
medicine for rheumatic disease treatment are each 476 and 580 per thousand patients in 1995
6
. 
 Curcuma xantorrhyza (temulawak) contains curcumin, essential oil, arabinose, fructose, 
glucose, starch, tannins and minerals which are magnesium, manganese, iron, copper, calcium, 
sodium, potassium, lead, zinc, cobalt, aluminum, and bismuth
7
. Curcumin has anti-inflammatory 
activities
8
. Curcumin is able to block cyclooxygenase, lipooxygenase and has activity as 
antioxidant
9
. 
Combination of 15 mg of curcuminoid from Curcuma domestica Val. rhizome extract and 
100 mg essential oil from Curcuma xanthorrhiza Roxb. consumed 2 times daily for 2 weeks is  
equal to anti-inflammatory drug piroxicam in improving the  osteoarthritic pain. Another 
advantage of the combination of turmeric rhizome extract curcuminoid and temulawak rhizome 
essential oil combination are the lower cost, higher effectiveness in improving physical 
conditions, and tends to improve liver, kidney, and gastrointestinal functions
10
. 
 Gingerol, shogaol, diarylheptanoids, and dialdehid diterpenes from ginger are able to 
inhibit prostaglandin production so they have anti-inflammatory activities
11
. 
Soybean contains isoflavone proven to suppress COX-2 which is an important pro-
inflammatory enzyme which converts arachidonic acid into prostaglandin causing pain and 
inflammation in osteoarthritis
12
. 
O 
Shrimp shell contains chondroitin and glucosamine which is a material for the formation of 
cartilage. Both have anti-inflammation effects and affect the cartilage metabolism by stimulating 
joint cartilage chondrocyte proteoglycan synthesis
13
. The combination of temulawak extract, 
ginger extract, soybean, and shrimp shell is hoped to reduce synovial fluid leukocyte count and 
joint pain in patients with osteoarthritis. 
 
METHOD 
 
Research Equipment 
1. Light microscope 
2. Leukocyte count chamber 
3. Validated visual analogue scale (VAS)  
 
Research Material 
1. Capsule which contains curcuma extract 50 mg, ginger extract 100 mg, shrimp shell 100 mg, 
and soy bean flour 50 mg 
2. Diclofenac sodium capsule 25 mg  
3. Synovial fluid obtained from knee joints of patients with osteoarthritis as much as 2ml. 
 
Research Subject 
 The subject of this study were diagnosed with knee osteoarthritis meeting the American 
College of Rheumatology (ACR) criteria which does not have other arthritis diseases besides 
osteoarthritis; no liver function, kidney or bone marrow disorder;  no history of gastritis, peptic 
ulceration, or duodenal ulceration; no hypersensitivity to curcuma or diclofenac sodium; and not 
using anticoagulant or other anti-inflammatory drugs.  
 
Course of Study 
This study is a prospective randomized open end blinded evaluation (PROBE) done in the 
Rheumatology polyclinic, Department of Internal Medicine, Medical Faculty Universitas Gadjah 
Mada / Dr. Sardjito Hospital – Yogyakarta in September until October 2010. 
Before the study began, subjects signed the informed consent. After that, randomization is 
done using a block 4 randomization so that the subjects are divided into 2 groups which are 
therapy group and control group. 
Patients in treatment group found the combination of those natural drug in capsuls and taken 
3 times daily while the control group is given diclofenac sodium 25 mg and taken 3 times daily. 
Synovial fluid is obtained from patients before and after 2 weeks of treatment for the 
leukocyte count. 
The visual analogue scale (VAS) was used for evaluated the drug effectiveness in reducing 
knee pain. Patients were asked to draw a perpendicular line towards the VAS line in which point 
the pain is felt according to the knee pain of the patient. Assessment is done before treatment and 
after 2 weeks of treatment. 
 
Statistical Analysis 
After data were obtained, it is analyzed using student’s t-test and Mann-Whitney-Wilcoxon 
test. To analyze the difference in synovial fluid leukocyte count before and after treatment the 
Wilcoxon signed ranks is used. Analysis of the effectiveness in reducing synovial fluid leukocyte 
count in both groups uses Mann-Whitney U test.  To analyze the difference in VAS score (pain 
degree) before and after treatment, paired t-test is used. Analysis of the effectiveness in reducing 
joint pain in both groups uses unpaired student’s t-test. Significance limit is acceptable if p < 0.05 
with Confidence Interval 95%. 
 
RESULTS AND DISCUSSION 
 
The prospective randomized open end blinded evaluation design used in this study is to 
avoid biases in the assessment of the response towards the drugs given in this study. The subjects 
are randomized using the block 4 randomization so that each group represents the subjects. It is 
expected that results with high validity can be obtained using this method. Before treatment there 
were 2 patients in which adequate synovial fluid can not be obtained for leukocyte count from 
treatment group, and after treatment there were 3 patients in whom adequate synovial fluid can 
not be obtained for leukocyte count from control group, thus results from these patients can not 
be analyzed. 
 
Baseline data of subjects can be seen in table 1. The baseline data between control and 
treatment group is not significantly different. Most of the subjects are women. This is consistent 
with epidemiologic data which shows that osteoarthritis is more prevalent in women compared to 
men
14
.
 
The mean age of the subjects are 63.00 ± 3.51 years old. This data shows that 
osteoarthritis is more common among the elderly. This is consistent with epidemiologic data 
which shows that osteoarthritis is a degenerative disease accompanied by inflammation
15
. 
Table 1. Baseline Data of Subjects Before Treatment 
 
Variable Number (%) Mean ± CI CI 95% MD P 
control 
(n=10) 
treatment 
(n=11) 
control (n=10) treatment 
(n=11) 
Lower Upper  
        
Gender 
- Male 
- Female 
 
4 (40%) 
6 (60%) 
 
2 (18.2%) 
9 (81.8%) 
    0.361 # 
Age (years old)   64.00 ± 9.02 62.09 ± 6.64 -5.28 9.09 0.585 * 
Education 
Elementary 
Middle 
High 
Tertiery 
 
 
 
6 (60%) 
4 (40%) 
 
2 (18.2%) 
1 (9.1%) 
7 (63.6%) 
1 (9.1%) 
    0.699 ♣ 
Duration of OA 
(month) 
  12.75 ± 6.75 24.36 ± 22.90   0.289 ☼ 
Location of  OA 
- Right 
- Left 
- Bilateral 
 
2 (20%) 
6 (60%) 
2 (20%) 
 
3 (27.3%) 
5 (45.4%) 
3 (27.3%) 
    1.000 ♣ 
BMI   28.85 ± 4.40 25.74 ± 3.19 -0.37 6.60 0.077 * 
Leukocyte count 
  5386.36 ± 
12149.49 
1000 ± 638.36 
  
0.594☼ 
VAS score (mm)   56.6 ± 23.23 50.86 ± 12.09 - 10.94 22.41 0.480 * 
Comorbidities 
- Hypertension 
- DM 
- Heart failure 
- Dyslipidemia 
 
2 (20%) 
2 (20%) 
- 
5 (50%) 
 
4 (36.4%) 
- 
1 (9.1%) 
6 (54.5%) 
     
0.367 # 
0.214 # 
0.524 # 
0.590 # 
# Chi-square / Fisher’s Exact test; * Independent t-test, ♣ Kolmogorov Smirnov test, ☼ Mann Whitney U test 
N = sample number            mm= milimeter 
CI = confidence interval     
MD CI 95% = Confidence Interval 95% Mean Difference 
 
Table 2. Results of VAS Score and Synovial Fluid Leukocyte Count Before and After Treatment 
 
Group control group (mean±CI) P value Treatment group (mean±CI) P value CI 95% MD 
Before treatment After treatment  Before 
treatment 
After 
treatment 
Lower Upper 
 
Leukocyte count 
/mm3 
 
VAS score (mm) 
 
7212.50±14027.26 
 
 
56.60 ± 23.23 
 
 
3033.75±7952.11 
 
 
41.20 ± 25.62 
 
 
0.017# 
 
 
0.012* 
 
1000.00±638.35 
 
 
50.86 ± 12.09 
 
52.22±131.41 
 
 
33.41 ± 17.34 
 
 
0.008# 
 
 
<0.001* 
 
 
9.99 
 
 
4.30 
 
 
24.91 
 
 
26.50 
 
N= sample number   mm= milimeter 
CI = confidence interval 
CI 95% MD= Confidence Interval 95% Mean Difference 
* unpaired T-test 
# Wilcoxon signed ranks 
 
Reviewed from education level, the most frequent education level in subjects is high 
school, thus in the filling of questionnaire there is no large bias
16
. The mean duration of subjects 
suffering from osteoarthritis is 18.71 ± 3.90 months. This shows that osteoarthritis is a chronic 
disease. Based on the baseline data of the subjects, there is no significant difference between 
control group and teatment group.   
Synovial fluid leukocyte count mean in the control group declines with p=0.017. This 
shows that the 25 mg diclofenac sodium capsule if given 3 times daily can reduce synovial fluid 
leukocyte count significantly in knee osteoarthritis patients. 
From VAS score assessment at the end of therapy in table 2, it can be known that the 
mean VAS score in control group declined (p=0.012). This shows that the 25mg diclofenac 
sodium capsule if given 3 times daily can reduce knee pain significantly in osteoarthritis patients.  
Pain is the result of an interaction between inflammation and other factors such as 
radiological disease severity, articular innervations, central and peripheral sensitization, and 
psychological factors
17
. 
The decline in synovial fluid leukocyte count and knee pain can be associated with the anti-
inflammatory activity of diclofenac sodium. Diclofenac sodium is a preferentially selective COX 
inhibitor which is a NSAID that suppresses COX-2 activities equal to suppressing COX-1 
activities although in reality tends to suppress COX-2 a little stronger. Suppression of COX-2 
enzyme activity inhibits prostaglandin E2 formation thus hampering joint inflammatory process. 
Diclofenac can also suppress pain stimulated by bradykinin
18,19
. 
Synovial fluid leukocyte count mean in the treatment group declines with p=0.008. This 
shows that the therapy capsule can lower synovial fluid leukocyte count significantly in 
osteoarthritis patients. From VAS score assessment at the end of therapy it can be known that the 
mean VAS score in therapy group declined (p<0.001). This shows that the therapy capsule which 
contains curcuma extract 50 mg, ginger extract 100 mg, shrimp shell 100 mg, and soy bean flour 
50 mg if given 3 times daily can reduce knee pain significantly in osteoarthritis patients. 
Lowering of synovial fluid leukocyte count and pain level can occur because each component in 
the combination has anti-inflammatory effects which lead to the lowering of synovial fluid 
leukocyte count.  
 Contained in the rhizome of temulawak are curcuminoids, essential oils, arabinose, 
fructose, glucose, starch, tannin and minerals such as magnesium, manganese, iron, copper, 
calcium, sodium, potassium, lead, zinc, cobalt, aluminum and bismuth
7
. The composition of 
temulawak curcuminoid contains curcumin and curcuminoids demetoxy
20
. Curcumin could 
Table 3. VAS Score and Synovial Fluid Leukocyte Count Difference Before and After Treatment 
Variable Mean±CI P 
value 
CI 95% MD 
Control group Treatment group Lower Upper  
∆ leukocyte 
count /mm3 
 
∆VAS score 
(mm) 
4178.75 ± 7088.14 
 
 
15.40 ± 15.51 
 
853.00 ± 696.22 
 
 
18.45 ± 11.05 
 
0.929# 
 
 
0.607* 
 
 
 
 
-15.26 
 
 
 
9.16 
 
N= sample number  mm= milimeter 
CI = confidence interval 
CI 95% MD= Confidence Interval 95% Mean Difference 
* paired T-test   # Mann-Whitney Test 
inhibit cyclooxygenase and lipooxygenase enzyme activity and act as antioxidants
9
. Curcumin is 
proven to be able to inhibit cyclooxygenase and lipooxygenase enzyme activity so that the 
production of prostaglandin E2 and leukotriene B4 and C4 are inhibited
21
. 
Ginger contains essential oil which consists of α-pinen, β-felandren, borneol, camphene, 
limonene, linalool, citral, nolyaldehide, decyladehide, metilheptenon, cineol, bisabolen, 1-α-
curcumen, farnesen, humulen, 60% zingiberene and evaporated Zingiber (gingerol pungent 
substance), namely 60-85% (6)-gingerol, (4)-gingerol, 5-15% (8)-gingerol, 6-21% (10)-gingerol, 
(12)-gingerol, (6)-methylgingerdiol, shogaol, zingeren, (6)-gingerdiol, diarylheptanoide, β-
bisabolene, (E)-α-farnesene. Ginger has anti-inflammatory potential obtained through the action 
of gingerol, shogaol, diarylheptanoids, and dialdehyd diterpens capable of inhibiting 
prostaglandin. It is proven in vitro that ginger extract has a strong potential for inhibiting 
egulating NF - 
relieve pain and other symptoms suffered by patients with OA
11, 22, 23
. 
Shrimp shell contains chondroitin and glucosamine which are formation materials of 
cartilage. The mechanism of action in the treatment of OA is not fully known. Both seem to have 
anti-inflammatory effect and affect the metabolism of cartilage proteoglycan by stimulating the 
synthesis of joint cartilage chondrocytes
13
. Some in vitro experiments showed synthesis 
stimulation of glycosaminoglycan and proteoglycans stimulate synovial production of hyaluronic 
acid is estimated as a mechanism in a study. Giving the combination of glucosamine and 
chondroitin sulfate reduces the intensity of moderate osteoarthritis knee pain compared to 
placebo
24
. 
Soybean contains isoflavones which are natural selective estrogen receptor modulators 
(SERMs), which may indicate partial estrogen agonist or antagonist action in tissue depending 
on some factors including estrogen receptor prevalence and intrinsic estrogen concentration
25
.   
Positive effects of isoflavone can be obtained from its direct effect towards cartilage. 
Articular cartilage is a tissue target of estrogen and for SERM such as isoflavone. Study 
conducted on animals suggests that intra-articular estrogen injection can increase the frequency 
and severity of osteoarthritis. Estrogen can also suppress proteoglycan synthesis and cause 
cartilage degeneration in osteoarthritis. Intra-articular estrogen injection can also disturb lactate 
dehydrogenase in chondrocytes, which continues with the disruption of collagen matrix. Soybean 
isoflavone can bind with estrogen receptors and give antagonistic effects towards local 
estrogen
25
.  
Soybean isoflavone is proven capable of suppressing pro-inflammation molecules such as 
COX-2 and NO in LPS-induced chondrocytes, but has no effects towards COX-1
12
. Other than 
isoflavone, another component of soybean (such as, soybean unsaponifiables) is also proven to 
hamper pro-inflammation cytokines in chondrocyte in vitro
25
.  
 
In table 3, it can be seen that both control group and therapy group can reduce synovial 
fluid leukocyte count significantly. The synovial fluid leukocyte count decline in the therapy 
group (mean 4178.75) compared to control group (mean 853.00) is not statistically significant 
(p=0.929). This shows that the effectiveness of the therapy group in reducing synovial fluid 
leukocyte count in knee osteoarthritis is not significantly different compared to the control group. 
In table 3, it can be seen that both control group and therapy group can reduce joint pain 
symptoms significantly. The decline in joint pain degree in the therapy group (mean 18.45 mm) 
is more prominent compared to control group (mean 15.4 mm), but statistically the difference is 
not significant (p=0.607). This shows that the effectiveness of the therapy group in reducing joint 
pain in knee osteoarthritis is not significantly different compared to the control group.  
 In this study, therapy is given in 2 weeks time. Addition of the therapy period is expected 
to increase the activity of the therapy drug in reducing synovial fluid leukocyte count and joint 
pain in osteoarthritis patients. The addition of sample size is also expected to increase the 
difference in the reduction of synovial fluid leukocyte count and joint pain in osteoarthritis 
patients. 
An advantage of this study is that the results of this study can be used as a consideration 
material by health workers to choose which therapy to use in reducing synovial fluid leukocyte 
count and joint pain in patients with osteoarthritis. Combination of temulawak extract, ginger 
extract, soybean, and shrimp shell is can be an alternative therapy for osteoarthritis to avoid the 
adverse effects caused by NSAIDs. Results of this study can also be used as an initial reference 
to conduct further clinical studies about that combination using a larger sample and a longer time 
period. This study is also useful in the development of herbal medicine science in Indonesia.
   
 
CONCLUSION 
1. The combination of temulawak extract, ginger extract, soybean, and shrimp shell given 3 
times daily can reduce synovial fluid leukocyte count and joint pain in osteoarthritis patients 
significantly in 2 weeks treatment. 
2. Effectiveness of this combinaion in reducing synovial fluid leukocyte count and joint pain in 
osteoarthritis is not significantly different compared to diclofenac sodium in 2 weeks treatment. 
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